Cargando…
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021
BACKGROUND: The extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744684/ https://www.ncbi.nlm.nih.gov/pubmed/36572604 http://dx.doi.org/10.1016/j.vaccine.2022.11.045 |
_version_ | 1784848975006793728 |
---|---|
author | Salvatore, Phillip P. Lee, Christine C. Sleweon, Sadia McCormick, David W. Nicolae, Lavinia Knipe, Kristen Dixon, Tom Banta, Robert Ogle, Isaac Young, Cristen Dusseau, Charles Salmonson, Shawn Ogden, Charles Godwin, Eric Ballom, TeCora Rhodes, Tara Wynn, Nhien Tran David, Ebenezer Bessey, Theresa K. Kim, Gimin Suppiah, Suganthi Tamin, Azaibi Harcourt, Jennifer L. Sheth, Mili Lowe, Luis Browne, Hannah Tate, Jacqueline E. Kirking, Hannah L. Hagan, Liesl M. |
author_facet | Salvatore, Phillip P. Lee, Christine C. Sleweon, Sadia McCormick, David W. Nicolae, Lavinia Knipe, Kristen Dixon, Tom Banta, Robert Ogle, Isaac Young, Cristen Dusseau, Charles Salmonson, Shawn Ogden, Charles Godwin, Eric Ballom, TeCora Rhodes, Tara Wynn, Nhien Tran David, Ebenezer Bessey, Theresa K. Kim, Gimin Suppiah, Suganthi Tamin, Azaibi Harcourt, Jennifer L. Sheth, Mili Lowe, Luis Browne, Hannah Tate, Jacqueline E. Kirking, Hannah L. Hagan, Liesl M. |
author_sort | Salvatore, Phillip P. |
collection | PubMed |
description | BACKGROUND: The extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and unvaccinated persons. METHODS: Consenting incarcerated persons with confirmed SARS-CoV-2 infection provided mid-turbinate nasal specimens daily for 10 consecutive days and reported symptom data via questionnaire. Real-time reverse transcription-polymerase chain reaction (RT-PCR), viral whole genome sequencing, and viral culture was performed on these nasal specimens. Duration of RT-PCR positivity and viral culture positivity was assessed using survival analysis. RESULTS: A total of 957 specimens were provided by 93 participants, of whom 78 (84 %) were vaccinated and 17 (16 %) were unvaccinated. No significant differences were detected in duration of RT-PCR positivity among vaccinated participants (median: 13 days) versus those unvaccinated (median: 13 days; p = 0.50), or in duration of culture positivity (medians: 5 days and 5 days; p = 0.29). Among vaccinated participants, overall duration of culture positivity was shorter among Moderna vaccine recipients versus Pfizer (p = 0.048) or Janssen (p = 0.003) vaccine recipients. In post-hoc analyses, Moderna vaccine recipients demonstrated significantly shorter duration of culture positivity compared to unvaccinated participants (p = 0.02). When restricted to participants without reported prior infection, the difference between Moderna vaccine recipients and unvaccinated participants was more pronounced (medians: 3 days and 6 days, p = 0.002). CONCLUSIONS: Infectious periods for vaccinated and unvaccinated persons who become infected with SARS-CoV-2 are similar and can be highly variable, though some vaccinated persons are likely infectious for shorter durations. These findings are critically important, especially in congregate settings where viral transmission can lead to large outbreaks. In such settings, clinicians and public health practitioners should consider vaccinated, infected persons to be no less infectious than unvaccinated, infected persons. |
format | Online Article Text |
id | pubmed-9744684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97446842022-12-13 Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 Salvatore, Phillip P. Lee, Christine C. Sleweon, Sadia McCormick, David W. Nicolae, Lavinia Knipe, Kristen Dixon, Tom Banta, Robert Ogle, Isaac Young, Cristen Dusseau, Charles Salmonson, Shawn Ogden, Charles Godwin, Eric Ballom, TeCora Rhodes, Tara Wynn, Nhien Tran David, Ebenezer Bessey, Theresa K. Kim, Gimin Suppiah, Suganthi Tamin, Azaibi Harcourt, Jennifer L. Sheth, Mili Lowe, Luis Browne, Hannah Tate, Jacqueline E. Kirking, Hannah L. Hagan, Liesl M. Vaccine Article BACKGROUND: The extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and unvaccinated persons. METHODS: Consenting incarcerated persons with confirmed SARS-CoV-2 infection provided mid-turbinate nasal specimens daily for 10 consecutive days and reported symptom data via questionnaire. Real-time reverse transcription-polymerase chain reaction (RT-PCR), viral whole genome sequencing, and viral culture was performed on these nasal specimens. Duration of RT-PCR positivity and viral culture positivity was assessed using survival analysis. RESULTS: A total of 957 specimens were provided by 93 participants, of whom 78 (84 %) were vaccinated and 17 (16 %) were unvaccinated. No significant differences were detected in duration of RT-PCR positivity among vaccinated participants (median: 13 days) versus those unvaccinated (median: 13 days; p = 0.50), or in duration of culture positivity (medians: 5 days and 5 days; p = 0.29). Among vaccinated participants, overall duration of culture positivity was shorter among Moderna vaccine recipients versus Pfizer (p = 0.048) or Janssen (p = 0.003) vaccine recipients. In post-hoc analyses, Moderna vaccine recipients demonstrated significantly shorter duration of culture positivity compared to unvaccinated participants (p = 0.02). When restricted to participants without reported prior infection, the difference between Moderna vaccine recipients and unvaccinated participants was more pronounced (medians: 3 days and 6 days, p = 0.002). CONCLUSIONS: Infectious periods for vaccinated and unvaccinated persons who become infected with SARS-CoV-2 are similar and can be highly variable, though some vaccinated persons are likely infectious for shorter durations. These findings are critically important, especially in congregate settings where viral transmission can lead to large outbreaks. In such settings, clinicians and public health practitioners should consider vaccinated, infected persons to be no less infectious than unvaccinated, infected persons. Elsevier Science 2023-03-10 2022-12-13 /pmc/articles/PMC9744684/ /pubmed/36572604 http://dx.doi.org/10.1016/j.vaccine.2022.11.045 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Salvatore, Phillip P. Lee, Christine C. Sleweon, Sadia McCormick, David W. Nicolae, Lavinia Knipe, Kristen Dixon, Tom Banta, Robert Ogle, Isaac Young, Cristen Dusseau, Charles Salmonson, Shawn Ogden, Charles Godwin, Eric Ballom, TeCora Rhodes, Tara Wynn, Nhien Tran David, Ebenezer Bessey, Theresa K. Kim, Gimin Suppiah, Suganthi Tamin, Azaibi Harcourt, Jennifer L. Sheth, Mili Lowe, Luis Browne, Hannah Tate, Jacqueline E. Kirking, Hannah L. Hagan, Liesl M. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title | Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title_full | Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title_fullStr | Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title_full_unstemmed | Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title_short | Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 |
title_sort | transmission potential of vaccinated and unvaccinated persons infected with the sars-cov-2 delta variant in a federal prison, july—august 2021 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744684/ https://www.ncbi.nlm.nih.gov/pubmed/36572604 http://dx.doi.org/10.1016/j.vaccine.2022.11.045 |
work_keys_str_mv | AT salvatorephillipp transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT leechristinec transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT sleweonsadia transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT mccormickdavidw transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT nicolaelavinia transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT knipekristen transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT dixontom transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT bantarobert transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT ogleisaac transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT youngcristen transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT dusseaucharles transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT salmonsonshawn transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT ogdencharles transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT godwineric transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT ballomtecora transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT rhodestara transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT wynnnhientran transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT davidebenezer transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT besseytheresak transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT kimgimin transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT suppiahsuganthi transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT taminazaibi transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT harcourtjenniferl transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT shethmili transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT loweluis transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT brownehannah transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT tatejacquelinee transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT kirkinghannahl transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 AT haganlieslm transmissionpotentialofvaccinatedandunvaccinatedpersonsinfectedwiththesarscov2deltavariantinafederalprisonjulyaugust2021 |